Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew L Hemming

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Biological Chemistry|September 13, 2005
Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitorMatthew L Hemming, Dennis J Selkoe
Neurobiology of Disease|February 27, 2007
Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer diseaseMatthew L Hemming, Dennis J Selkoe, Wesley Farris
Plos One|December 31, 2009
Identification of beta-secretase (BACE1) substrates using quantitative proteomicsMatthew L Hemming, Joshua E Elias, Steven P Gygi, et al.
Plos Biology|October 24, 2008
Proteomic profiling of gamma-secretase substrates and mapping of substrate requirementsMatthew L Hemming, Joshua E Elias, Steven P Gygi, et al.
Biochemistry|April 27, 2005
Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-proteinWesley Farris, Malcolm A Leissring, Matthew L Hemming, et al.
Plos Medicine|September 1, 2007
Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer diseaseMatthew L Hemming, Michaela Patterson, Casper Reske-Nielsen, et al.
Nature Genetics|March 18, 2003
Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivityChristopher J Winrow, Matthew L Hemming, Duane M Allen, et al.
Molecular Cancer Research : MCR|June 11, 2020
Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic SubtypesMatthew L Hemming, Changyu Fan, Chandrajit P Raut, et al.
Gynecologic Oncology|April 10, 2017
YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapyMatthew L Hemming, Andrew J Wagner, Marisa R Nucci, et al.
Cancer Research|April 24, 2024
ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional ProgramsEwa Sicinska, Vijaya S R Kola, Joseph A Kerfoot, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Biological Chemistry|September 13, 2005
Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitorMatthew L Hemming, Dennis J Selkoe
Neurobiology of Disease|February 27, 2007
Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer diseaseMatthew L Hemming, Dennis J Selkoe, Wesley Farris
Plos One|December 31, 2009
Identification of beta-secretase (BACE1) substrates using quantitative proteomicsMatthew L Hemming, Joshua E Elias, Steven P Gygi, et al.
Plos Biology|October 24, 2008
Proteomic profiling of gamma-secretase substrates and mapping of substrate requirementsMatthew L Hemming, Joshua E Elias, Steven P Gygi, et al.
Biochemistry|April 27, 2005
Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-proteinWesley Farris, Malcolm A Leissring, Matthew L Hemming, et al.
Plos Medicine|September 1, 2007
Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer diseaseMatthew L Hemming, Michaela Patterson, Casper Reske-Nielsen, et al.
Nature Genetics|March 18, 2003
Loss of neuropathy target esterase in mice links organophosphate exposure to hyperactivityChristopher J Winrow, Matthew L Hemming, Duane M Allen, et al.
Molecular Cancer Research : MCR|June 11, 2020
Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic SubtypesMatthew L Hemming, Changyu Fan, Chandrajit P Raut, et al.
Gynecologic Oncology|April 10, 2017
YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapyMatthew L Hemming, Andrew J Wagner, Marisa R Nucci, et al.
Cancer Research|April 24, 2024
ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional ProgramsEwa Sicinska, Vijaya S R Kola, Joseph A Kerfoot, et al.
Pageof 3